TCR-redirected T cells targeting CT antigen

· Adaptimmune

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TCR-redirected T cells targeting CT antigen, covering 2019-01-03 to 2019-01-03. Get the full timeline:

Most recent: Clinical Trial Update: CT Antigen TCR-redirected T Cells for Ovarian Cancer. [Phase 1, Phase 2]